Skip to main content

2 Result(s)

within Elena Mata Remove this filter Hepatology Remove this filter

and

  1. No Access

    Article

    Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

    To determine the efficacy and safety data of aflibercept + FOLFIRI in wt RAS mCRC patients after progression to standard chemotherapy + anti-EGFR treatment.

    Ruth Vera, Elena Mata, Encarna González… in International Journal of Colorectal Disease (2020)

  2. No Access

    Article

    Complications from the primary tumour are not related with survival in patients with synchronous stage IV colorectal cancer receiving chemotherapy without primary tumour resection

    The aim of this study was to evaluate the rate of complications from the primary tumour (CPT) requiring surgical or endoscopic intervention during chemotherapy treatment in patients with incurable synchronous ...

    Javier Suárez, Gabriel Marín, Ruth Vera… in International Journal of Colorectal Disease (2015)